Cancer Immunotherapy Markets The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics including Executive and Consultant Guides and a Complete Listing of Active Company Summaries. 2020 to 2024
Publication Date: June 2, 2019
351 Pages packed with information
“Disruptive technology to change therapeutics .....”
The technologies and opportunities are explored. Over one hundred companies are profiled. Our research makes you the expert.
A revolution in cancer therapy is underway. New therapy based on using the body’s natural immune defenses is having unprecedented success. This is a complex area but our readable reports help you understand it, both the technology and the opportunity.
The technology is moving faster than the market. Already worth billions the global market is poised for dramatic growth. Is the cure in sight? The impact on the health care industry is enormous. The report forecasts the market size out to 2023.
Use independent research that makes you the expert. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. Get an extra player on your team as unlimited assistance and breakout data is included with your purchase.
CAR – T Cells? Checkpoint Inhibitors? Cytokines? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
See the Table of Contents.
Email firstname.lastname@example.org for complimentary sample pages.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research and the American Association for Clinical Chemistry.
He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research - Burke Institute
Finance for Senior Executives - Harvard Business School